Physician

Eduardo Braun, M.D.

According to 2025 Medicare claims, Eduardo Braun, M.D. (NPI: 1144486309) practices hematology/oncology in the Michigan City-La Porte, IN market, with the plurality of this provider's patient population coming from La Porte, IN. This provider's primary affiliated billing organization is NORTHWEST CANCER CENTERS, PC (NPI: 1578527826; TIN: 30-0200047) and primary practice location at 46350-3112. Braun is affiliated with the Franciscan ACO, Inc. (ACO ID: A2550) and UCMCNACO, LLC (ACO ID: A3531), participating under the MSSP model.

Braun's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 349 traditional Medicare patients, billed 103,532 HCPCS/CPT codes, and received $1,813,076 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,049 prescription claims across 170 beneficiaries totaling $3,310,104 in drug costs, led by Calquence (Acalabrutinib Maleate). 2023 DME data shows 43 claims. Open Payments data shows 79 records totaling $4,957. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $567,066 to $3,310,104. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	573	335,923	$3,787,625
2016	591	320,706	$4,046,653
2017	593	395,665	$4,534,140
2018	594	412,653	$5,229,652
2019	609	440,197	$5,498,477
2020	570	341,995	$4,825,241
2021	498	233,468	$3,577,154
2022	629	244,268	$3,242,345
2023	535	185,155	$2,859,075
2024	349	103,532	$1,813,076

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	137	1,112	$567,066
2016	203	1,487	$956,301
2017	217	1,657	$1,350,971
2018	226	1,830	$1,919,961
2019	256	1,719	$2,350,662
2020	255	1,765	$2,901,241
2021	283	1,904	$3,166,314
2022	318	2,158	$4,583,698
2023	265	1,431	$3,547,056
2024	170	1,049	$3,310,104

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	72	$7,198
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	43	$8,354
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	166	327	$65
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	189	387	$12
36415	Insertion of needle into vein for collection of blood sample	198	663	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	181	626	$8
82247	Bilirubin level, total	148	442	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Calquence	Acalabrutinib Maleate	37	1,110	$573,039
Ojjaara	Momelotinib Dihydrochloride	17	510	$485,649
Revlimid	Lenalidomide	24	532	$315,005
Ibrance	Palbociclib	19	532	$295,688
Sprycel	Dasatinib	11	330	$188,667

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	79	$4,957	Janssen Scientific Affairs, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Eduardo Braun, M.D.?

Tedicare shows public-source Medicare data for Eduardo Braun, M.D. (NPI 1144486309), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eduardo Braun, M.D. have ACO affiliation data?

Eduardo Braun, M.D. is shown with ACO affiliation data for Franciscan ACO, Inc. (MSSP, ACO ID A2550) and UCMCNACO, LLC (MSSP, ACO ID A3531).

What billing organization is linked to Eduardo Braun, M.D.?

Eduardo Braun, M.D. is linked to NORTHWEST CANCER CENTERS, PC (billing NPI 1578527826) in the available physician profile data.

Does Eduardo Braun, M.D. have Open Payments data?

Eduardo Braun, M.D. has 79 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.